Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages
Authors:
- 22 May 2023
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 46 (5) , 1749-1763
Abstract
As a lethal infectious disease, tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb). Its complex pathophysiological process limits the effectiveness of many clinical treatments. By regulating host cell death, Mtb manipulates macrophages, the first line of defense against invading pathogens, to evade host immunity and promote the spread of bacteria and intracellular inflammatory substances to neighboring cells, resulting in widespread chronic inflammation and persistent lung damage. Autophagy, a metabolic pathway by which cells protect themselves, has been shown to fight intracellular microorganisms, such as Mtb, and they also play a crucial role in regulating cell survival and death. Therefore, host-directed therapy (HDT) based on antimicrobial and anti-inflammatory interventions is a pivotal adjunct to current TB treatment, enhancing anti-TB efficacy. In the present study, we showed that a secondary plant metabolite, ursolic acid (UA), inhibited Mtb-induced pyroptosis and necroptosis of macrophages. In addition, UA induced macrophage autophagy and enhanced intracellular killing of Mtb. To investigate the underlying molecular mechanisms, we explored the signaling pathways associated with autophagy as well as cell death. The results showed that UA could synergistically inhibit the Akt/mTOR and TNF-α/TNFR1 signaling pathways and promote autophagy, thus achieving its regulatory effects on pyroptosis and necroptosis of macrophages. Collectively, UA could be a potential adjuvant drug for host-targeted anti-TB therapy, as it could effectively inhibit pyroptosis and necroptosis of macrophages and counteract the excessive inflammatory response caused by Mtb-infected macrophages via modulating the host immune response, potentially improving clinical outcomes.Keywords
All Related Versions
Funding Information
- National Key Research and Development Program of China (2021YFE0200900, 2021YFE0200900, 2021YFE0200900, 2021YFE0200900, 2021YFE0200900)
- National Natural Science Foundation of China (81873069, 81873069, 81873069, 81873069, 81873069)
- Shanghai Municipal Science and Technology Major Project (ZD2021CY001, ZD2021CY001, ZD2021CY001, ZD2021CY001, ZD2021CY001)
This publication has 46 references indexed in Scilit:
- Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosisImmunological Reviews, 2015
- Macrophage defense mechanisms against intracellular bacteriaImmunological Reviews, 2015
- Necroptosis, in vivo detection in experimental disease modelsSeminars in Cell & Developmental Biology, 2014
- The DNA Damage-Regulated Autophagy Modulator DRAM1 Links Mycobacterial Recognition via TLR-MYD88 to Autophagic DefenseCell Host & Microbe, 2014
- Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatmentBMC Complementary and Alternative Medicine, 2013
- Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammationProceedings of the National Academy of Sciences, 2012
- Genetic Basis of Virulence Attenuation Revealed by Comparative Genomic Analysis of Mycobacterium tuberculosis Strain H37Ra versus H37RvPLOS ONE, 2008
- On the origin, evolution, and nature of programmed cell death: a timeline of four billion yearsCell Death & Differentiation, 2002
- Lymphocyte Recruitment and Protective Efficacy against Pulmonary Mycobacterial Infection Are Independent of the Route of PriorMycobacterium bovisBCG ImmunizationInfection and Immunity, 2002
- The interaction of p62 with RIP links the atypical PKCs to NF‐κB activationThe EMBO Journal, 1999